Cancer Research AACR Membership  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lloyd, D. R.
Right arrow Articles by Hanawalt, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lloyd, D. R.
Right arrow Articles by Hanawalt, P. C.
[Cancer Research 62, 5288-5294, September 15, 2002]
© 2002 American Association for Cancer Research


Molecular Biology and Genetics

p53 Controls Global Nucleotide Excision Repair of Low Levels of Structurally Diverse Benzo(g)chrysene-DNA Adducts in Human Fibroblasts1

Daniel R. Lloyd and Philip C. Hanawalt2

Department of Biological Sciences, Stanford University, Stanford, California 94305-5020 [P. C. H.], and Research School of Biosciences, University of Kent, Canterbury, Kent, CT2 7NJ, United Kingdom [D. R. L.]

Benzo(g)chrysene is a widespread environmental contaminant and potent carcinogen. We have measured the formation and nucleotide excision repair of covalent DNA adducts formed by the DNA-reactive metabolite of this compound in human fibroblasts, in which expression of the p53 tumor suppressor gene could be controlled by a tetracycline-inducible promoter. Cells were exposed for 1 h to 0.01, 0.1, or 1.2 µM (±)-anti-benzo(g)chrysene diol-epoxide, and DNA adducts were assessed at various post-treatment times by subjecting isolated DNA to 32P-postlabeling analysis. Four major DNA adducts were detected, corresponding to the reaction of either the (+)- or (-)-anti-benzo(g)chrysene diol-epoxide stereoisomer with adenine or guanine. Treatment with 1.2 µM resulted in a level of 1100 total adducts/108 nucleotides for both p53-proficient and -deficient cells; removal of adducts was not observed in either case. In cells treated with 0.1 µM, the maximum level of total adducts at 24 h was 150/108 nucleotides in p53-proficient cells and 210 adducts/108 nucleotides in p53-deficient cells. A concentration of 0.01 µM resulted in a maximum of 20 adducts/108 nucleotides in p53-proficient cells at 4 h, but 40 adducts/108 nucleotides persisted in p53-deficient cells at 24 h. Whereas there were clear differences in the time course of adduct levels in p53-proficient compared with p53-deficient cells treated with 0.1 µM or 0.01 µM, these levels did not decrease extensively over 3 days. This is likely because of the stabilization of the diol-epoxide in cells, and consequent exposure and formation of adducts for many hours after the initial treatment. Furthermore, despite minor quantitative differences, all 4 of the adducts behaved similarly with respect to the effect of p53 expression on their removal. p53 appears to minimize the appearance of benzo(g)chrysene adducts in human cells by up-regulating global nucleotide excision repair and reducing the maximum adduct levels achieved. The fact that this p53-dependent effect is noted at levels of DNA adducts that are commonly found in human tissues (i.e., <100 adducts/108 nucleotides) because of environmental factors such as smoking is particularly significant with respect to human carcinogenesis related to environmental exposure.




This article has been cited by other articles:


Home page
MutagenesisHome page
S. Bhana, A. Hewer, D. H. Phillips, and D. R. Lloyd
p53-dependent global nucleotide excision repair of cisplatin-induced intrastrand cross links in human cells
Mutagenesis, March 1, 2008; 23(2): 131 - 136.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
S. Bhana and D. R. Lloyd
The role of p53 in DNA damage-mediated cytotoxicity overrides its ability to regulate nucleotide excision repair in human fibroblasts
Mutagenesis, January 1, 2008; 23(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Medina and F. S. Kittrell
p53 Function Is Required for Hormone-Mediated Protection of Mouse Mammary Tumorigenesis
Cancer Res., October 1, 2003; 63(19): 6140 - 6143.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.